| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $300.0M | +71.5% |
| SG&A Expense | $112.8M | +15.2% |
| Operating Income | -$437.1M | -23.4% |
| Interest Expense | $5.6M | -81.6% |
| Pre-tax Income | -$602.2M | -16.6% |
| Income Tax | $61K | -74.6% |
| Net Income | -$602.2M | -16.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.0M | -96.6% |
| Current Assets | $84.5M | -86.1% |
| Total Assets | $529.3M | -41.7% |
| Current Liabilities | $268.2M | -8.7% |
| Total Liabilities | $328.3M | -3.4% |
| Stockholders' Equity | $201.0M | -64.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$383.1M | -12.7% |
| Capital Expenditures | $123.2M | +28.8% |
| Investing Cash Flow | -$123.2M | -28.8% |
| Financing Cash Flow | -$6.7M | -100.7% |
| Free Cash Flow | -$506.3M | -16.3% |